Rocket Pharmaceuticals

Rocket Pharmaceuticals(RCKTW)

NEW YORK, NY
Pharmaceutical1 H-1B visas (FY2023)

Focus: Gene Therapies

Rocket Pharmaceuticals is a life sciences company focused on Gene Therapies.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
Leukocyte Adhesion Deficiency
N/A
Clinical Trials (1)
NCT06282432Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
N/A
Clinical Trials (1)
NCT03311165Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)
N/A
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Respiratory Disease
N/A
Clinical Trials (1)
NCT03661801Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
N/A
Heart Transplant
Danon Disease
N/A
Clinical Trials (1)
NCT05548855Natural History of Danon Disease
N/A
Group-based Acceptance and Commitment Therapy
Acute Stroke Patients With Depression
N/A
Clinical Trials (1)
NCT05727358Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression
N/A
Vacuum-Based IPC
Pleural Effusion
N/A
Clinical Trials (1)
NCT03831386Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System
N/A
The Natural History of Danon Disease
Danon Disease
N/A
Clinical Trials (1)
NCT03766386The Natural History of Danon Disease
N/A
N/A
Clinical Trials (1)
NCT06082414Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants
N/A
Digital Pleural Manometry
Pleural Effusion, Malignant
N/A
Clinical Trials (1)
NCT02805062Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy
N/A
Pleural procedures
Malignant Pleural Effusion
N/A
Clinical Trials (1)
NCT04793607Interventions for Malignant Pleural Effusions Impact on Fatigue
N/A
Delayed transanal pull-through anastomosis
Rectal Cancer
N/A
Clinical Trials (1)
NCT06662643A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
N/A
Safety and efficacy assessments
Fanconi Anemia Complementation Group A
N/A
Clinical Trials (1)
NCT04437771Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy
N/A
No intervention
Danon Disease
N/A
Clinical Trials (1)
NCT06214507Danon Disease Natural History Study
N/A
PKP2-ACM Natural History Study
Cardiomyopathies
N/A
Clinical Trials (1)
NCT06644742PKP2-ACM Natural History Study
N/A
Clostridium butyricum
Rectal Cancer
N/A
Clinical Trials (1)
NCT07369830The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
N/A
Device: Butterfly iQ
Covid19
N/A
Clinical Trials (1)
NCT04967729COVID-19 and Lung Ultrasound Utility
N/A
Transarterial infusion chemotherapy
Unresectable Colorectal Cancer
N/A
Clinical Trials (1)
NCT07333053Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
N/A
N/A
Clinical Trials (1)
NCT03319186EDIT Management Feasibility Trial
N/A
Clinical Trials (1)
NCT04525352A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
Phase 1
RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74
Dilated Cardiomyopathy (DCM)
Phase 1
Clinical Trials (1)
NCT07137338A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Phase 1
Phase 1
Clinical Trials (1)
NCT03882437Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Phase 1
Bone Marrow Aspiration
Fanconi Anemia
Phase 1
Clinical Trials (1)
NCT01331018Gene Therapy for Fanconi Anemia
Phase 1
Clinical Trials (1)
NCT03825783A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
Phase 1
Clinical Trials (1)
NCT03814408A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A
Phase 1
Clinical Trials (1)
NCT04105166Gene Therapy for Pyruvate Kinase Deficiency (PKD)
Phase 1
Clinical Trials (1)
NCT05885412A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Clinical Trials (1)
NCT03812263A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
Phase 1/2
Clinical Trials (1)
NCT06422351Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency
Phase 2
Clinical Trials (1)
NCT04248439Gene Therapy for Fanconi Anemia, Complementation Group A
Phase 2
Phase 2
Clinical Trials (1)
NCT06092034A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Phase 2
Clinical Trials (1)
NCT04069533Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
Phase 2
Clinical Trials (1)
NCT06312982A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Phase 2/3
SIS-reinforced anastomosis
Rectal Cancer
Phase 4
Clinical Trials (1)
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Phase 4
Clinical Trials (1)
NCT02937974Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 34 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available

Financials (FY2025)

Revenue
$0
R&D Spend
$171M3%
Net Income
-$259M
Cash
$164M

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 2 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub